Relevant bibliographies by topics / Hormone replacement therapy

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Hormone replacement therapy'

Author: Grafiati
Published: 4 June 2021
Last updated: 27 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hormone replacement therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hormone replacement therapy"

1

Lochner, Heather V., and Thomas A. Einhorn. "Hormone Replacement Therapy." Journal of the American Academy of Orthopaedic Surgeons 12, no. 5 (September 2004): 291–94. http://dx.doi.org/10.5435/00124635-200409000-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hillard, Amanda. "Hormone replacement therapy." Nursing Standard 10, no. 22 (February 21, 1996): 51–56. http://dx.doi.org/10.7748/ns.10.22.51.s51.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ottaway, Elizabeth. "Hormone replacement therapy." Nursing Standard 4, no. 47 (August 15, 1990): 28–30. http://dx.doi.org/10.7748/ns.4.47.28.s30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

&NA;. "Hormone replacement therapy." Reactions Weekly &NA;, no. 369 (September 1991): 9. http://dx.doi.org/10.2165/00128415-199103690-00040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

&NA;. "Hormone replacement therapy." Reactions Weekly &NA;, no. 379 (November 1991): 8. http://dx.doi.org/10.2165/00128415-199103790-00032.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Montgomery Rice, Valerie. "Hormone Replacement Therapy." Drugs & Aging 19, no. 11 (2002): 807–18. http://dx.doi.org/10.2165/00002512-200219110-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Whittington, Ruth, and Diana Faulds. "Hormone Replacement Therapy." PharmacoEconomics 5, no. 5 (May 1994): 419–45. http://dx.doi.org/10.2165/00019053-199405050-00008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Whittington, Ruth, and Diana Faulds. "Hormone Replacement Therapy." PharmacoEconomics 5, no. 6 (June 1994): 513–54. http://dx.doi.org/10.2165/00019053-199405060-00007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bluming, Avrum. "Hormone-Replacement Therapy." Oncology Times 25, no. 3 (February 2003): 4–5. http://dx.doi.org/10.1097/01.cot.0000294140.61650.cd.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rudy, David R. "Hormone replacement therapy." Postgraduate Medicine 88, no. 8 (December 1990): 157–64. http://dx.doi.org/10.1080/00325481.1990.11704777.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Hormone replacement therapy"

1

Habiba, Marwan A. "Endometrial responses to hormone replacement therapy." Thesis, University of Leicester, 1998. http://hdl.handle.net/2381/30471.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ödmark, Inga-Stina. "Hormone replacement therapy : benefits and adverse effects /." Umeå : Univ, 2004. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-243.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ödmark, Inga-Stina. "Hormone replacement therapy : benefits and adverse effects." Doctoral thesis, Umeå universitet, Obstetrik och gynekologi, 2004. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-243.

Full text
Abstract:
Background: Numerous studies have shown that estrogen replacement therapy (ERT) is an effective treatment for vasomotor symptoms, insomnia and vaginal dryness. Beneficial effects have also been shown on lipid patterns and on the incidence of osteoporotic fractures. As ERT increases the risk of endometrial adenocarcinoma, combinations with various progestogens have been developed in order to protect the endometrium. However, the addition of progestogens tends to reduce the beneficial effects of estrogens on mood, cognition and lipid metabolism. The added progestogen often causes side effects such as irritability and depression. There is evidence that the effect on wellbeing varies between women and with the type of progestogen used. Women who prefer to avoid withdrawal bleedings can be given continuous combined hormone replacement therapy (HRT). Unfortunately, irregular bleedings are common at the beginning of treatment and reduces compliance. Recently, several studies have reported an increased risk of breast cancer and venous thrombosis, and therefore long-term treatment with HRT for women without climacteric symptoms is no longer recommended. The ongoing debate has, for the time being, resulted in a recommendation that improving quality of life (QoL) by treatment of climacteric symptoms should be the only indication for prescribing HRT. Aims and methods: The aims of the study were to investigate bleeding patterns, changes in wellbeing at onset and during long-term treatment, and lipid and lipoprotein profiles with two different types of continuous combined HRT. In addition, women starting, and women switching from mainly sequential HRT were compared. The design was a randomised, double-blind, one year, prospective, multicentre study including 249 healthy postmenopausal women who were given continuous daily oral treatment with either combined 0.625mg conjugated estrogen (CE) and 5mg medroxyprogesterone acetate (MPA) or combined 2mg 17β - estradiol (E2) and 1mg norethisterone acetate (NETA). Bleedings, if any, were recorded daily throughout the study. The main outcome measures (changes in wellbeing and climacteric symptoms) consisted of daily ratings of 12 items on a validated symptom scale. Serum concentrations of lipids and lipoproteins were measured at baseline and after one year of treatment. Results and conclusions: The majority of drop-outs were confined to the first three months, and the main reasons were bleedings and/or decreased wellbeing. Drop-outs were three times more common in the E2/NETA group. During the first month, 67% of the women reported irregular bleedings. The number of bleeding days decreased on both treatments during the first four months. Treatment with CE/MPA resulted in less irregular bleedings and a shorter time to amenorrhoea compared to E2/NETA. As expected, "starters" experienced more sweats than "switchers" at the onset of treatment, but both groups improved significantly. Side effects such as breast tenderness, swelling, depression and irritability appeared during the first treatment week in both groups. The side effects of HRT appeared much more quickly than the benefits and were more frequent in women with a history of premenstrual syndrome (PMS). Breast tenderness was more common in the E2/NETA group throughout the whole study period. Apart from that, there were no differences between the two treatment regimens as regards effects on well-being at the end of the study. Lipoprotein(a) levels, an important risk factor for cardiovascular disease, decreased in both treatment groups. Triglyceride levels increased in women treated with CE/MPA, and levels of total cholesterol, high density lipoprotein and low density lipoprotein fell in the E2/NETA group. In conclusion, treatment with E2/NETA caused more bleeding problems than treatment with CE/MPA. CE/MPA was better tolerated than E2/NETA at the beginning of the study, but among the women remaining in the study there was no difference in QoL between the two treatment groups. HRT counselling should take into account that a history of PMS increases the likelihood of side effects and that these may precede any beneficial effects. Both treatments produced beneficial effects on lipid and lipoprotein levels, and neither of the regimens was superior in this respect.
APA, Harvard, Vancouver, ISO, and other styles
4

Björn, Inger. "Hormone replacement therapy and effects on mood." Doctoral thesis, Umeå universitet, Obstetrik och gynekologi, 2003. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-94115.

Full text
Abstract:
Background: During the past 5 decades, hormone replacement therapy (HRT) has been used, and appreciated for its beneficial effects, by millions of women in their menopause. As treatment for climacteric symptoms, estrogen is outstanding, and effects on hot flushes, vaginal dryness, and insomnia have been widely documented. The increased risks of venous thrombosis and breast cancer, however, restrict the use of estrogen. Estrogen treatment in women with a remaining uterus includes a progestin, added to protect the endometrium from hyperplasia and malignancies. The long-standing clinical impression, that progestin addition negatively influences mood, has been discussed in previous studies. Mood deterioration is, however, not mortal, although mood is important to the wellbeing and daily functioning of women treated with hormones. Studies of the mental side effects of HRT add to our understanding of steroid effects in the brain. Aims and methods: In our studies, we aimed to establish to what extent negative side effects cause women to discontinue HRT, and find out which drug compounds lead to mood deterioration. The questions asked were whether the type and dose of progestin and the estrogen dose during the progestin addition influence the mood and physical symptoms during sequential HRT. Compliance with HRT and reasons for discontinuing the therapy were evaluated in a retrospective longitudinal follow-up study. Treatment effects were studied in three randomized, double-blind, cross-over trials. During continuous estrogen treatment, effects of sequential addition of a progestin were studied by comparing two different progestins, medroxyprogesterone acetate (MPA) andnorethisterone acetate (NETA), comparing different doses of the same progestin, MPA, and comparing two doses of estrogen during addition of the same dose of MPA. The main outcome measure was the daily rating on mood and physical symptoms kept by the participants throughout the studies. The clinical trials were carried out at three gynecological centers in northern Sweden. Results and conclusions: Besides fear of cancer and a wish to determine whether climacteric symptoms had meanwhile disappeared, negative side effects was the most common reason or discontinuing HRT. Tension in the breasts, weight gain, a depressed mood, abdominal bloating, and irritability were the most important side effects seen both in women who continued HRT and in women who had discontinued the therapy. In our clinical trials, we showed that addition of a progestin to estrogen treatment induces cyclic mood swings characterized by tension, irritability, and depression, as well as increased breast tension, bloatedness, and hot flushes. Women with a history of premenstrual syndrome (PMS) appeared to be more sensitive to the progestin addition and responded with lower mood scores compared with women without previous PMS. In our studies, MPA provoked depressed mood to a lesser extent than did NETA. Surprisingly, the higher dose of MPA (20 mg) enhanced the mood, compared with 10 mg, when added to estrogen treatment. In women continuously treated with 3 mg estradiol, mood and physical symptoms worsened during the progestin addition, as compared with treatment with 2 mg estradiol. The negative side effects seen during sequential HRT have much in common with symptoms seen in the premenstrual dysphoric disorder (PMDD), which is a psychoneuroendocrine disorder with psychiatric expression. Explanations for treatment effects on mood are likely to be found in drug interactions with neurotransmitter systems of the brain.

Diss. (sammanfattning) Umeå : Umeå universitet, 2003


digitalisering@umu
APA, Harvard, Vancouver, ISO, and other styles
5

Homer, Natalie. "Erythocyte oxidative stress : focus on hormone replacement therapy." Thesis, University of Strathclyde, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.273852.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Daly, Edel. "Balancing the benefits and risks of hormone replacement therapy." Thesis, University of Oxford, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.393609.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Griffiths, Frances Ellen. "Hormone replacement therapy : perspectives from women, medicine and sociology." Thesis, Durham University, 1997. http://etheses.dur.ac.uk/5084/.

Full text
Abstract:
Developed on the boundary between medicine and sociology, this thesis develops a critique of the perspectives of these disciplines through analysis of a study of women's perspectives on hormone replacement therapy. Women's perspectives are explored through a postal questionnaire survey and a study using individual interviews and focus groups. The survey results provide a measure of women’s attitudes towards, and knowledge of, hormone replacement therapy. The individual interviews detail the way women move towards a decision about the therapy and identifies common themes, particularly women's fears and what influences their fears. The focus groups explore contrasting themes including women's control and choice in decisions about therapy, contrary themes in women’s attitudes and the different ways of thinking used by the women. The results of the studies are assessed for their implications for clinical general practice. The thesis also takes a sociological perspective on women and HRT and on the research process, in particular exploring two themes. Firstly, the interaction between the social context, the research subject and the research process. This includes the social factors influencing the development of the research and choice of research methods, and the influence of the research methods on the results obtained. The second theme is the perspectives and levels of analysis used by the main disciplines contributing to the thesis; biomedicine, biostatistics, general practice and sociology. The thesis explores how the different perspectives and levels of analysis influence research and how they are used to manage the social context. These explorations are used to suggest future directions for research on hormone replacement therapy and for general practice.
APA, Harvard, Vancouver, ISO, and other styles
8

Armstrong, Alison L. "Hormone replacement therapy - effects on strength, balance and bone density." Thesis, University of Nottingham, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.284686.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Towne, Cheryl Luann Rush. "Older women's beliefs about hormone replacement therapy : a qualitative study /." View online, 2000. http://repository.eiu.edu/theses/docs/32211130976791.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Riman, Tomas. "An epidemiologic study of epithelial ovarian malignancies : with a focus on hormone-related factors /." Stockholm, 2003. http://diss.kib.ki.se/2003/91-7349-362-7/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Hormone replacement therapy"

1

T, Khaw K., ed. Hormone replacement therapy. Edinburgh: Churchill Livingstone, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wayne, Meikle A., ed. Hormone replacement therapy. Totowa, N.J: Humana Press, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Meikle, A. Wayne, ed. Hormone Replacement Therapy. Totowa, NJ: Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-700-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

HRT: Hormone replacement therapy. New York: DK Pub., 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Burger, Henry G., ed. Sex Hormone Replacement Therapy. Boston, MA: Springer US, 2000. http://dx.doi.org/10.1007/978-1-4757-6507-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kleerekoper, Michael. Hormone replacement therapy and osteoporosis. London: Parthenon, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

R, Johnson Susan, ed. Menopause and hormone replacement therapy. Philadelphia: Saunders, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kato, J., H. Minaguchi, and Y. Nishino, eds. Hormone Replacement Therapy and Osteoporosis. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-662-04021-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Junzo, Kato, Minaguchi H. 1933-, and Nishino Y, eds. Hormone replacement therapy and osteoporosis. Berlin: Springer, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Brisco, Paula. The hormone replacement handbook. Allentown, Pa: People's Medical Society, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Hormone replacement therapy"

1

Hirshkowitz, Max, Claudia Orengo, and Glenn R. Cunningham. "Androgen Replacement." In Hormone Replacement Therapy, 307–28. Totowa, NJ: Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-700-0_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Marshall, Lorna A. "Hormone Replacement Therapy." In Encyclopedia of Women’s Health, 607–9. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-0-306-48113-0_203.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Schwab, Manfred. "Hormone Replacement Therapy." In Encyclopedia of Cancer, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-27841-9_2815-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Janssen, Joseph A. M. J. L., Aart Jan van der Lely, Alan D. Rogol, and Adriana G. Ioachimescu. "Hormone Replacement Therapy." In Pituitary Disorders, 265–76. Oxford, UK: Wiley-Blackwell, 2013. http://dx.doi.org/10.1002/9781118559406.ch26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kennard, Elizabeth A. "Hormone Replacement Therapy." In Menopause, 139–54. Totowa, NJ: Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-246-3_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

von der Lohe, Elisabeth. "Hormone Replacement Therapy." In Coronary Heart Disease in Women, 175–203. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-55553-4_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shively, Carol A. "Hormone replacement therapy." In Encyclopedia of psychology, Vol. 4., 158–60. Washington: American Psychological Association, 2000. http://dx.doi.org/10.1037/10519-071.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Inman, Wendelyn, Alexis Heaston, Revlon Briggs, and Rosemary Theriot. "Hormone Replacement Therapy." In Handbook of Healthcare in the Arab World, 101–6. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-36811-1_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Inman, Wendelyn, Alexis Heaston, Revlon Briggs, and Rosemary Theriot. "Hormone Replacement Therapy." In Handbook of Healthcare in the Arab World, 1–6. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-74365-3_8-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cummings, David E., and George R. Merriam. "Growth Hormone and Growth Hormone Secretagogues in Adults." In Hormone Replacement Therapy, 61–88. Totowa, NJ: Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-700-0_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Hormone replacement therapy"

1

Bunting, Haley A., Ryan T. Cassilly, Brian Jin, Christopher S. Ahmad, Louis U. Bigliani, William N. Levine, and Thomas R. Gardner. "Effect of Hormone Therapy on Tensile Strain of the Macaque Inferior Glenohumeral Ligament." In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53531.

Full text
Abstract:
The effect of hormone treatment on the material properties of ligaments has been extensively studied for the anterior cruciate ligament (ACL). However, there have been few studies on the effects of hormones on the material properties of the shoulder. Shoulder ligaments contribute to overall shoulder stability, and a change in ligament properties could contribute to a change in overall shoulder laxity. Cynomolgus monkeys have served as nonhuman primate models in studies examining the effects of hormone replacement therapy on the cardiovascular system, as well as serving as a model for menopause, reproductive support structures, the knee joint and shoulder joint. The cynomolgus macaques are commonly used for studies involving hormone replacement therapy because they have 28-day menstrual cycles with very similar hormonal patterns to that of women. This study uses female cynomologus macaque (Macaca fascicularis) monkeys as an animal model of the human shoulder to determine if estrogen has an effect on the strain distribution of the inferior glenohumeral ligament (IGHL).
APA, Harvard, Vancouver, ISO, and other styles
2

Gardner, Thomas R., Ryan T. Cassilly, Brian Jin, Anuli N. Mkparu, Christoper S. Ahmad, Louis U. Bigliani, and William N. Levine. "Effect of Estrogen on Viscoelastic Properties of the Anterior Pouch of the Macaque Animal Model of the Inferior Glenohumeral Ligament." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206835.

Full text
Abstract:
The effect of hormone treatment on the material properties of ligaments has been extensively studied for the anterior cruciate ligament (ACL). However, there have been very few studies on the effects of hormones on the material properties of the shoulder. These shoulder ligaments contribute to overall shoulder stability, and a change in ligament properties could contribute to a change in overall shoulder laxity. This study uses female cynomologus macaque (Macaca fascicularis) monkeys as an animal model of the human shoulder to determine if estrogen has an effect on the viscoelastic properties of the anterior pouch of the inferior glenohumeral ligament (IGHL). Cynomolgus monkeys have served as nonhuman primate models in several studies, including monkey models of menopause, the effects of hormone replacement therapy on the cardiovascular system, reproductive support organs, and the knee joint. The cynomolgus macaques are commonly used for studies involving hormone replacement therapy because they have 28-day menstrual cycles with very similar hormonal patterns to that of women.
APA, Harvard, Vancouver, ISO, and other styles
3

Zhang, P., and J. G. Zein. "Menopausal Hormone Replacement Therapy and Risk of Asthma." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7089.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vieira, Amanda Cristina de Souza, Antônio Pedro Oliveira de Vasconcelos, Jaqueline Maria Pinheiro de Araujo, Juliana Comin Müller, Larissa de Cassia Afonso Magalhães, Renato Duarte da Silva, Ricardo Baroni Vieira, and Fabiana Candida de Queiroz Santos Anjos. "EPIDEMIOLOGICAL RELATIONSHIP BETWEEN HORMONE REPLACEMENT THERAPY AND BREAST CANCER." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2090.

Full text
Abstract:
Objective: The aim of this study was to epidemiologically analyze the hormone replacement therapy (HRT) and the emergence of breast cancer. Methodology: This is an article review from the databases such as LILACS, SciELO, Bireme, and Medscape, utilizing the keywords: menopause, HRT, breast cancer and complications, employing the use of connectors when necessary. This review aims to elucidate what has been published in the last years about the usage of hormone therapy and the emergence of breast cancer since there are disagreements between the literature. Results: The analysis displayed positive effects during the usage of HRT, such as maintenance of bone density, prevention of fractures, and cardiovascular events in patients with no previous changes in this system, and also showed us a strong relationship between HRT and the incidence of breast cancer in menopausal women with a focus into the imposing time of use ratio. Meanwhile, this development risk of breast CA can be reduced in the long run with the withdrawal of the previously initiated therapy. The progesterone HRT has been shown to have lower risks in association with estrogen than when compared with the association of synthetic progestins and estrogen. Associations have similar results for oral and skin HRT. In patients using the postmenopausal hormone therapy, the risk of mortality from breast cancer was reduced in patients with exposure for a maximum of 5 years, more than 5–10 years, or more than 10 years. Conclusion: In view of the exposure, it is considered that the HRT is more beneficial than malefic to the life and health of women. Meanwhile, the risk of breast CA goes up while the HRT time stretches over the years. Thus, it is necessary to individually evaluate the benefits and risks to better identify the therapy that should be utilized.
APA, Harvard, Vancouver, ISO, and other styles
5

Triebner, Kai, Simone Accordini, Lucia Calciano, Ane Johannessen, Bryndís Benediktsdóttir, Ersilia Bifulco, Pascal Demoly, et al. "Hormone replacement therapy may preserve lung function during reproductive aging." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.oa4420.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dembo, Anna, and Geoffrey Greene. "Abstract 5044: Reducing breast cancer risk with hormone replacement therapy." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-5044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Caldwell, Jon-Michael E., Ryan T. Cassilly, Haley A. Bunting, Christopher S. Ahmad, Louis U. Bigliani, William N. Levine, and Thomas R. Gardner. "Effects of Hormone Therapy on Regional Surface Strain as a Function of Applied Strain in the Macaque Inferior Glenohumeral Ligament." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80840.

Full text
Abstract:
Hormones such as estrogen are known to have an effect on the biomechanical properties of certain ligaments such as the anterior cruciate ligament in the knee; however, relatively little is known about its effect on the ligaments of the shoulder. The inferior glenohumeral ligament (IGHL) is a static stabilizer of the shoulder that prevents anterior translation of the humeral head. Alterations to the properties of this ligament can result in capsular stretching, increased laxity, and ultimately instability. The cynomolgus macaque (Macaca fascicularis) shares many hormonal similarities with humans including a 28-day menstrual cycle and is a commonly used model for hormone replacement therapy studies. This study uses the female cynomolgus monkey as a model of the human shoulder to determine if estrogen has an effect on the regional surface strain behavior of the inferior glenohumeral ligament.
APA, Harvard, Vancouver, ISO, and other styles
8

Hamy, AS, H. Gronier, R. Porcher, S. Giacchetti, C. Cuvier, Roquancourt A. De, and M. Espie. "P4-10-09: Hormone Replacement Therapy: A Benign Breast Disease's Risk?" In Abstracts: Thirty-Fourth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 6‐10, 2011; San Antonio, TX. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/0008-5472.sabcs11-p4-10-09.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Miyachi, K., A. Ihara, and B. Sasse. "THU0695 Does hormone replacement therapy prevent undifferentiated arthritis progressing to rheumatoid arthritis." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.4077.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sören Halvard Hansen, Erik, Kristian Aasbjerg, Amalie Lykkemark Møller, Elisabeth Gade, Christian Torp-Pedersen, and Vibeke Backer. "Women receiving hormone replacement therapy are at high risk of developing asthma." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.1430.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Hormone replacement therapy"

1

Huang, Xi. Hormone Replacement Therapy, Iron, and Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, October 2005. http://dx.doi.org/10.21236/ada448472.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Huang, Xi. Hormone Replacement Therapy, Iron, and Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, November 2004. http://dx.doi.org/10.21236/ada433028.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Manosroi, Worapaka, and Pichitchai Atthakomol. Hormone replacement therapy and risk of carpal tunnel syndrome: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2022. http://dx.doi.org/10.37766/inplasy2022.8.0018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Harvey, Jennifer A., Richard J. Santen, Gina R. Petroni, Viktor E. Bovberg, and Mark B. Williams. Increasing Mammographic Breast Density in Response to Hormone Replacement Therapy and Breast Cancer Risk. Fort Belvoir, VA: Defense Technical Information Center, October 2002. http://dx.doi.org/10.21236/ada412142.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Harvey, Jennifer A. Increasing Mammographic Breast Density in Response to Hormone Replacement Therapy and Breast Cancer Risk. Fort Belvoir, VA: Defense Technical Information Center, October 2003. http://dx.doi.org/10.21236/ada424557.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Modugno, Francesmary. Prospective Evaluation of Hormone Replacement Therapy, Body Mass Index, Estrogen Metabolism and Breast Cancer Risk. Fort Belvoir, VA: Defense Technical Information Center, July 2003. http://dx.doi.org/10.21236/ada417504.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Reding, Kerryn W. An Epidemiologic Study of Genetic Variation in Hormonal Pathways in Relation to the Effect of Hormone Replacement Therapy on Breast Cancer Risk. Fort Belvoir, VA: Defense Technical Information Center, April 2008. http://dx.doi.org/10.21236/ada486465.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Reding, Kerryn W. An Epidemiologic Study of Genetic Variation in Hormonal Pathways in Relation to the Effect of Hormone Replacement Therapy on Breast Cancer Risk. Fort Belvoir, VA: Defense Technical Information Center, October 2008. http://dx.doi.org/10.21236/ada501717.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Liu, Gejing, Man Ren, Yingshi Du, Xinni Xu, Ruoyu Zhao, Yu Wu, Yongming Liu, and Liang Qi. A meta-analysis of Effect of thyroid hormone replacement therapy on the Cardiac diastolic function in Patients with Subclinical Hypothyroidism. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2023. http://dx.doi.org/10.37766/inplasy2023.2.0083.

Full text
Abstract:
Review question / Objective: P:Subclinical Hypothyroidism(Age over 18); I:thyroid hormone replacement therapy; C:baseline(before-after study in the same patient); O:Cardiac diastolic function measurement by echocardiography. Condition being studied: Subclinical hypothyroidism is associated with anomalies left ventricular diastolic functions, however, there are still disputes about whether to use levothyroxine for treatment. This meta-analysis aimed to determine whether levothyroxine (LT4), commonly used to treat hypothyroidism, affects cardiovascular indices in SCH patients as measured by echocardiography.
APA, Harvard, Vancouver, ISO, and other styles
10

Rada, Maria Patricia, Alexandra Caseriu, Roxana Crainic, and Stergios K. Doumouchtsis. A critical appraisal and systematic review of clinical practice guidelines on hormone replacement therapy for menopause: assessment using the Appraisal of Guidelines for Research and Evaluation (AGREE II) Instrument. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2022. http://dx.doi.org/10.37766/inplasy2022.12.0089.

Full text
Abstract:
Review question / Objective: To assess the quality of clinical practice guidelines (CPC) on hormone replacement therapy for menopause using the AGREE II instrument and to provide a summary of recommendations. Information sources: Literature searches using MEDLINE, Embase, Scopus, Geneva Foundation for Medical Education and Research from inception to date will be searched. The search terms include guidelines / guidance / recommendation and hormone replacement therapy related keywords and MeSH terms. National and international organizations websites will be searched individually. Additional searches on the references of the primary included items may help identify any guidelines missed on the primary searches. In the case of more than one published guideline from the same national or international association, only the latest version of the guidelines will be included and evaluated. Any disagreements on inclusion criteria will be addressed through discussion and consensus meeting within the research team. Guidelines published in languages other than English will be considered on an individual basis. Guidelines must be publicly available on a website or in a peer-reviewed publication.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Hormone replacement therapy' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography